Caligan Partners LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Caligan Partners LP held in its portfolio 21 assets valued at $1,214,792,770 (i.e. $1.22B).

The most valuable assets in the portfolio included: LIQUIDIA CORPORATION ($280.02M), ABIVAX SA ($195.80M), and MINERALYS THERAPEUTICS INC ($184.03M).

The chart below shows the top 10 valuable assets, and the table below shows the top 21 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Caligan Partners LP Portfolio

LIQUIDIA CORPORATION

ABIVAX SA

MINERALYS THERAPEUTICS INC

REVOLUTION MEDICINES INC

VAXCYTE INC

EXELIXIS INC

ADMA BIOLOGICS INC

XENON PHARMACEUTICALS INC

INHIBRX BIOSCIENCES INC

TANGO THERAPEUTICS INC

Caligan Partners LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
LIQUIDIA CORPORATION	8118892	280020585	COM NEW
ABIVAX SA	1451924	195799211	SPONSORED ADS
MINERALYS THERAPEUTICS INC	5071054	184028550	COM
REVOLUTION MEDICINES INC	1283900	102262635	COM
VAXCYTE INC	1704815	78660164	COM
EXELIXIS INC	1553262	68079473	COM
ADMA BIOLOGICS INC	3012508	54948146	COM
XENON PHARMACEUTICALS INC	1099365	49273539	COM
INHIBRX BIOSCIENCES INC	473565	37411635	COM
TANGO THERAPEUTICS INC	3729895	33046870	COM
TYRA BIOSCIENCES INC	944257	24824517	COM
MAZE THERAPEUTICS INC	550191	22794413	COM
RAPT THERAPEUTICS INC	644400	21825828	COM NEW
AVALO THERAPEUTICS INC	881533	16008639	COM NEW
ANIKA THERAPEUTICS INC	1435130	13791599	COM
VOR BIOPHARMA INC	925067	9962972	COM NEW
INVENTIVA SA	2000000	9300000	ADS
VERRICA PHARMACEUTICALS INC	923910	7677692	COM SHS
AGIOS PHARMACEUTICALS INC	90000	2449800	COM
SPRUCE BIOSCIENCES INC	20514	1786975	COM NEW
ELEDON PHARMACEUTICALS INC	555978	839527	COM